BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29243911)

  • 1. Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes.
    Chen K; Bennett SA; Rana N; Yousuf H; Said M; Taaseen S; Mendo N; Meltser SM; Torrente MP
    ACS Chem Neurosci; 2018 Apr; 9(4):838-848. PubMed ID: 29243911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.
    Bennett SA; Tanaz R; Cobos SN; Torrente MP
    Transl Res; 2019 Feb; 204():19-30. PubMed ID: 30391475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models.
    Bennett SA; Cobos SN; Meykler M; Fallah M; Rana N; Chen K; Torrente MP
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30958470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
    Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
    Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of histone post-translational modifications in neurodegenerative diseases.
    Cobos SN; Bennett SA; Torrente MP
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1982-1991. PubMed ID: 30352259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
    Hishikawa N; Niwa J; Doyu M; Ito T; Ishigaki S; Hashizume Y; Sobue G
    Am J Pathol; 2003 Aug; 163(2):609-19. PubMed ID: 12875980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
    Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?
    Ludolph AC; Brettschneider J
    Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of neurodegenerative diseases: with special reference to Parkinson's disease and amyotrophic lateral sclerosis].
    Takahashi H
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1085-7. PubMed ID: 12784672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes.
    Masala A; Sanna S; Esposito S; Rassu M; Galioto M; Zinellu A; Carru C; Carrì MT; Iaccarino C; Crosio C
    Neuroscience; 2018 Oct; 390():1-11. PubMed ID: 30134203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration.
    Shafi S; Singh A; Gupta P; Chawla PA; Fayaz F; Sharma A; Pottoo FH
    CNS Neurol Disord Drug Targets; 2021; 20(1):54-67. PubMed ID: 32885763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
    Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
    Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations.
    Ayaki T; Ito H; Komure O; Kamada M; Nakamura M; Wate R; Kusaka H; Yamaguchi Y; Li F; Kawakami H; Urushitani M; Takahashi R
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):128-138. PubMed ID: 29272468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.
    Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L
    Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.